HUTCHMED (China) Limited
HCMNASDAQHealthcare● Active
$10.85
$-0.02(-0.18%)
Market Cap$1.9B
P/E Ratio—
52W High$19.5
52W Low$10.71
HUTCHMED (China) Limited (HCM) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HCM · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.46B | $0.04B | $0.10B | ($0.36B) | ($0.17B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.02B | $0.04B | $0.03B | $0.04B |
| Change in Working Capital | ($0.06B) | ($0.06B) | $0.07B | $0.06B | $0.03B |
| Net Cash from Operations | ($0.06B) | $0.00B | $0.22B | ($0.27B) | ($0.20B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.02B) | ($0.03B) | ($0.04B) | ($0.02B) |
| Purchases of Investments | ($2.75B) | ($1.85B) | ($1.63B) | ($1.20B) | ($1.37B) |
| Sales of Investments | $2.74B | $1.77B | $1.37B | $1.52B | $0.92B |
| Net Cash from Investing | ($0.03B) | ($0.10B) | ($0.29B) | $0.30B | ($0.31B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.04B) | ($0.01B) | ($0.05B) | ($0.03B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | ($0.09B) | ($0.10B) |
| Debt Issued / Repaid | $0.01B | $0.01B | $0.06B | ($0.01B) | ($0.00B) |
| Net Cash from Financing | $0.01B | ($0.03B) | $0.05B | ($0.08B) | $0.65B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.08B) | ($0.02B) | $0.19B | ($0.31B) | ($0.22B) |
| FCF Margin %(computed) | -14.37% | -2.77% | 22.27% | -71.59% | -62.05% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more HUTCHMED (China) Limited data
About HUTCHMED (China) Limited (HCM) Cash Flow Statement
HUTCHMED (China) Limited generated operating cash flow of ($0.06B) and free cash flow of ($0.08B) for 2025 — a FCF margin of -14.37%. Capital expenditure was ($0.01B).
Frequently asked questions
HCM · 4 questionsHUTCHMED (China) Limited generated free cash flow of ($0.08B) for 2025, down 353.2% year-over-year.
HCM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10